JFG
ABBV icon

JDM Financial Group’s AbbVie ABBV Stock Holding History

JDM Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22
Closed -$4.34K – 338
2024
Q3 		$4.34K Buy
+22
New +$4.11K ﹤0.01% 222
2023
Q2 		– Sell
-107
Closed -$17.1K – 210
2023
Q1 		$17.1K Hold
107
– – 0.02% 106
2022
Q4 		$17.3K Buy
+107
New +$16.4K 0.02% 104

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JDM Financial Group's ABBV Position: Q4 2024 in Review

JDM Financial Group sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 22 shares — an estimated $4.34K sold.

JDM Financial Group first reported a position in ABBV in Q4 2022 and held it in 3 quarters. The position peaked at $17.3K in Q4 2022. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • JDM Financial Group reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • JDM Financial Group sold 22 AbbVie shares in Q4 2024, an estimated $4.34K.
  • JDM Financial Group first reported a position in AbbVie in Q4 2022 and held it in 3 quarters.
  • JDM Financial Group's AbbVie position peaked at $17.3K in Q4 2022.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on JDM Financial Group's 13F filing for Q4 2024, filed 18 Feb 2025.